Cargando…

Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases

Diabetes mellitus (DM) negatively affects the development and progression of chronic liver diseases (CLD) of various etiologies. Concurrent DM and CLD are also associated with worse clinical outcomes with respect to mortality, the occurrence of hepatic decompensation, and the development of hepatoce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Waihong, Promrat, Kittichai, Wands, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522556/ https://www.ncbi.nlm.nih.gov/pubmed/33033564 http://dx.doi.org/10.4254/wjh.v12.i9.533

Ejemplares similares

Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020
por: Kalligeros, Markos, et al.
Publicado: (2023)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants
por: Siddique, Osama, et al.
Publicado: (2018)

Doxycycline-Induced Autoimmune Hepatitis
por: Pan, Jason Jeng, et al.
Publicado: (2020)

A Call to Action: Alcohol Interventions in HIV-Infected Patients
por: Leggio, Lorenzo, et al.
Publicado: (2012)

Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives
por: García-Compeán, Diego, et al.
Publicado: (2022)

Identification of Nonalcoholic Fatty Liver Disease following Pancreatic Surgery in a Western Cohort Using a Novel Radiographic Technique
por: Olefson, Sidney, et al.
Publicado: (2015)

Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase
por: Shapiro, Jason M., et al.
Publicado: (2016)

Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and Management
por: Oliva-Damaso, Nestor, et al.
Publicado: (2021)

Acetaldehyde adducts in alcoholic liver disease
por: Setshedi, Mashiko, et al.
Publicado: (2010)

Hepatitis B virus genetic variants: biological properties and clinical implications
por: Tong, Shuping, et al.
Publicado: (2013)

Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
por: Zhao, Yingying, et al.
Publicado: (2019)

Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes
por: Licata, Anna, et al.
Publicado: (2023)

Inhibition of Lymphocyte Cytotoxicity by Serum from Patients with Alcoholic Liver Disease: Partial Characterization of Serum Inhibitors
por: Wands, J. R., et al.
Publicado: (1978)

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
por: Huang, Chiung-Kuei, et al.
Publicado: (2016)

The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments
por: de la Monte, Suzanne M., et al.
Publicado: (2018)

Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease
por: Canillas, Lidia, et al.
Publicado: (2023)

Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2014)

Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2019)

Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test
por: Nishida, Tsutomu
Publicado: (2017)

Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management
por: Zhang, Ze-Yu, et al.
Publicado: (2020)

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
por: Gambato, Martina, et al.
Publicado: (2020)

Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management
por: Cruz-Gonzalez, Ignacio, et al.
Publicado: (2022)

Advances in ultrasound diagnosis in chronic liver diseases
por: Maruyama, Hitoshi, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Insulin Resistance, Ceramide Accumulation, and Endoplasmic Reticulum Stress in Human Chronic Alcohol-Related Liver Disease
por: Longato, Lisa, et al.
Publicado: (2012)

Diagnosis and Management of Alcoholic Liver Disease
por: Dugum, Mohannad, et al.
Publicado: (2015)

Challenges in Clinical Diagnosis and Management of Chronic Endometritis
por: Yasuo, Tadahiro, et al.
Publicado: (2022)

Management of COVID-19 patients with chronic liver diseases and liver transplants
por: Hu, Xinyu, et al.
Publicado: (2022)

Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management
por: Casali, Lucio, et al.
Publicado: (2013)

COVID-19 in patients with liver disease and liver transplant: clinical implications, prevention, and management
por: Perreault, Gabriel, et al.
Publicado: (2023)

Management of alcohol use disorder in patients with chronic liver disease
por: Mellinger, Jessica L., et al.
Publicado: (2023)

Patient-Centered Self-Management in Patients with Chronic Kidney Disease: Challenges and Implications
por: Lin, Chiu-Chu, et al.
Publicado: (2020)

Management of Pruritus in Chronic Liver Disease
por: Bhalerao, Angeline, et al.
Publicado: (2015)

Clinical Implications of Glucose Variability: Chronic Complications of Diabetes
por: Jung, Hye Seung
Publicado: (2015)

Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease
por: Merli, Manuela, et al.
Publicado: (2023)

Sarcopenia: Clinical implications in ovarian cancer, diagnosis, etiology, and management
por: Seol, Aeran, et al.
Publicado: (2020)

Implication of Nanoparticles to Combat Chronic Liver and Kidney Diseases: Progress and Perspectives
por: Hashim, Mariam, et al.
Publicado: (2022)

Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management
por: Kośnik, Artur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fj2ksnqkb0h6fbo06ukb0b6cb0